BirdoTech Chongqing CDMO production base has a promising future!

Birdo (Chongqing) Pharmatech Co.,Ltd CDMO production base (Phase I) covers an area of 100 acres, with a total construction area of about 37,960.40 square metres, and will be mainly engaged in the research and development and production of pharmaceutical raw materials and other pharmaceutical drugs after completion, creating a comprehensive, three-dimensional, scientific and green platform for a full-process integrated CDMO centred on green process technology. Birdo (Chongqing) Pharmatech Co.,Ltd has been successfully selected into Chongqing Science and Technology Enterprise Database. In addition, BirdoTech Chongqing drug R&D service platform has been completed and put into operation in Chongqing International Bio-city in 2021, which greatly improves Dutron Pharma's service capability and will synergise with BirdoTech Chongqing CDMO production base to provide customers with high-quality integrated services. Rooted in Chongqing, radiating to the southwest and serving the world, BirdoTech Chongqing will help promote the competitiveness of the pharmaceutical industry in the western region and contribute to the future of human health!